… IVIG therapy in the treatment of viral diseases and guiding the treatment process of patients
with COVID-19 in this section, we review the IVIG therapy … ) showed that IVIG therapy can be …

… IVIg was a safe and effective treatment for COVID-19-related encephalopathy in our case
series. Clinical efficacy may be driven by the anti-inflammatory action of IVIg, associated with …

… of IVIg in hospitalised adult COVID-19 … IVIg therapy in hospitalised adult COVID-19 patients
were pooled and analysed in this meta-analysis. Overall, our results suggest that IVIg therapy …

… therapeutic efficacy of IVIG to COVID-19, we retrospectively collected the clinical and outcome
data of critical COVID-19 … ) in China, and using IVIG as an exposure factor analysed the …

… In the context of COVID-19, the actual role of IVIG … IVIG for the treatment of COVID-19 in 12
patients (9 male) with an average age of 50 years (range 23–74 years) and severe COVID-19. …

… of the efficacy of IVIG therapy in critically ill patients with COVID-19 pneumonia. However, …
In summary, initiation of IVIG as adjuvant treatment for COVID-19 pneumonia within 48 h of …

… immunoglobulin (IVIG) in coronavirus disease-19 (COVID-19). It … how IVIG benefits severe
and critically ill COVID-19 patients. … IVIG reduces IL-6 and C-reactive protein in the COVID-19 …

… a potential therapy for coronavirus disease 2019 (COVID‐19). This review was previously
part of a parent review addressing convalescent plasma and hIVIG for people with COVID‐19 …

… IVIg may be more effective in protecting the host, as demonstrated in mice [5]. To address the
potential protective effect of IVIg against COVID-19 … assessed possible COVID-19 infection …

… of IVIG (Intravenous Immunoglobulin) therapy for COVID-19 remains controversial. We
performed a meta-analysis to investigate the efficacy of IVIG treatment in patients with COVID-19. …